These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 24565579)
1. Genes and pathology of non-small cell lung carcinoma. Sakashita S; Sakashita M; Sound Tsao M Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579 [TBL] [Abstract][Full Text] [Related]
2. Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations. Murugan P; Stevenson ME; Hassell LA Arch Pathol Lab Med; 2014 Jan; 138(1):105-9. PubMed ID: 24377817 [TBL] [Abstract][Full Text] [Related]
3. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS]. Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987 [No Abstract] [Full Text] [Related]
4. The classification of lung carcinoma: time to change the morphology-based approach? Pelosi G; Sonzogni A; Viale G Int J Surg Pathol; 2010 Jun; 18(3):161-72. PubMed ID: 20460313 [TBL] [Abstract][Full Text] [Related]
5. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements. Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671 [TBL] [Abstract][Full Text] [Related]
6. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung. Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP; Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401 [No Abstract] [Full Text] [Related]
7. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. Rossi G; Pelosi G; Barbareschi M; Graziano P; Cavazza A; Papotti M Int J Surg Pathol; 2013 Aug; 21(4):326-36. PubMed ID: 23740564 [TBL] [Abstract][Full Text] [Related]
8. Pathology of non-small cell lung cancer. New diagnostic approaches. Linnoila I Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774 [TBL] [Abstract][Full Text] [Related]
9. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099 [TBL] [Abstract][Full Text] [Related]
10. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations. Tomaszek SC; Huebner M; Wigle DA Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911 [TBL] [Abstract][Full Text] [Related]
11. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885 [TBL] [Abstract][Full Text] [Related]
12. Implications for powering biomarker discovery studies. Dibben SM; Holt RJ; Davison TS; Wilson CL; Taylor J; Paul I; McManus K; Kelly PJ; Proutski V; Harkin DP; Kerr P; Fennell DA; James JA; Kennedy RD J Mol Diagn; 2012; 14(2):130-9. PubMed ID: 22251612 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers. Hanabata T; Tsukuda K; Toyooka S; Yano M; Aoe M; Nagahiro I; Sano Y; Date H; Shimizu N Oncol Rep; 2004 Jul; 12(1):177-80. PubMed ID: 15201980 [TBL] [Abstract][Full Text] [Related]
14. Common and contrasting genomic profiles among the major human lung cancer subtypes. Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734 [TBL] [Abstract][Full Text] [Related]
15. [Changes in classiffication of primary lung adenocarcinoma according to reccomendations of International Association for the Study of Lung Cancer/ /American Thoracic Society/European Respiratory Society]. Szołkowska M; Langfort R; Szczepulska-Wójcik E; Maksymiuk B Pneumonol Alergol Pol; 2012; 80(2):163-71. PubMed ID: 22370986 [No Abstract] [Full Text] [Related]
16. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer]. Wu Y; Wu Y; Wang L; Qu L Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291 [TBL] [Abstract][Full Text] [Related]
18. New agents in advanced non-small-cell lung cancer treatment. Ricciardi S; de Marinis F Oncology; 2009; 77 Suppl 1():103-12. PubMed ID: 20130438 [TBL] [Abstract][Full Text] [Related]
19. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas. Rossi G; Graziano P; Leone A; Migaldi M; Califano R Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286 [TBL] [Abstract][Full Text] [Related]
20. Tissue sampling in lung cancer: a review in light of the MERIT experience. Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]